Revised SPC: Granocyte (lenograstim) pre-filled syringe
SPC now highlights that cases of venous thromboembolism and arterial thromboembolism (such as myocardial infarction and cerebrovascular event) have been reported in donors treated with lenograstim. Close monitoring is now recommended in donors and patients with known risk factors
Source:
electronic Medicines compendium